Healthtech funding in 2015
European Healthtech startup funding raised during 2015.
In 2015, 211 European Healthtech companies closed 228 funding rounds and raised €1.8B in equity funding (excluding debt and grants). Debt rounds added €103M. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 18 Nov 2026.
Equity funding
€1.8B
excl. debt & grants · +€103M debt
Funding rounds
228
Companies
211
Top country
Switzerland
Healthtech: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2013 | €631M | +31.5% | 121 | +63.5% | €914k |
| 2014 | €928M | +47.1% | 134 | +10.7% | €649k |
| 2015 | €1.8B | +89.5% | 228 | +70.1% | €103M |
Rank among sectors
#4
8.8% of sector funding
Debt financing
€103M
5.5% of total
Top-10 round share
36.4%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2015 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €102M | 16 |
| Feb | €873k | 6 |
| Mar | €79M | 15 |
| Apr | €171M | 19 |
| May | €81M | 14 |
| Jun | €56M | 17 |
| Jul | €119M | 21 |
| Aug | €207M | 11 |
| Sep | €405M | 29 |
| Oct | €184M | 26 |
| Nov | €378M | 31 |
| Dec | €102M | 23 |
Top countries
by € raisedHealthtech — top countries by capital, 2015 — interactive chart.
Data table
| Healthtech — top countries by capital, 2015 | |
|---|---|
| Switzerland | €395M |
| UK | €362M |
| Israel | €206M |
| France | €188M |
| Germany | €182M |
| Netherlands | €115M |
| Denmark | €92M |
| Sweden | €85M |
Stage mix
by € raisedHealthtech — stage mix, 2015 — interactive chart.
Data table
| Healthtech — stage mix, 2015 | |
|---|---|
| Series B | €375M |
| Series C | €367M |
| Series A | €326M |
| Growth/Late | €296M |
| Series D+ | €209M |
| Debt | €103M |
| Early VC | €91M |
| Seed | €76M |
| Grant | €24M |
| Other | €19M |
Exits & M&A
13 Acquisition · 2 Buyout15 exits · €821M disclosed.
| Biotie Therapies | Acquisition | Sep 2015 | €330M |
| Dezima Pharma | Acquisition | Mar 2015 | €273M |
| WiThings | Acquisition | Dec 2015 | €170M |
| ClipFort | Acquisition | Dec 2015 | €26M |
| AMO Pharma | Buyout | Jun 2015 | €23M |
Largest equity rounds
by disclosed amount, 2015| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Series D+ | Nov 2015 | €100M |
| CeQur | Series C | Sep 2015 | €89M |
| Benevolent | Growth/Late | Aug 2015 | €80M |
| Merus | Series C | Aug 2015 | €73M |
| ADC Therapeutics | Growth/Late | Sep 2015 | €71M |
| CRISPR Therapeutics | Series B | Apr 2015 | €59M |
| ObsEva | Series B | Nov 2015 | €54M |
| CureVac | Series D+ | Mar 2015 | €46M |
| Kymab | Series B | May 2015 | €45M |
| Sanifit | Series C | Sep 2015 | €37M |
Largest debt rounds
debt financing, 2015; not in the equity totalTop investors
most active in 2015, by deal count- High-Tech Gründerfonds (HTGF)10 deals
- Caixa Capital Risc4 deals
- Imperial Innovations Limited4 deals
- New Enterprise Associates4 deals
- OurCrowd4 deals
- VI Partners4 deals
- Abingworth LLP3 deals
- BioMedPartners3 deals
- Bpifrance3 deals
- Cabiedes & Partners3 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology